HAEMONETICS CORP 4
4 · HAEMONETICS CORP · Filed Jul 3, 2007
Insider Transaction Report
Form 4
Popovsky Mark A
VP, Corporate Medical Director
Transactions
- Sale
Common Stock
2007-07-02$52.79/sh−7,000$369,504→ 3,552 total - Exercise/Conversion
Common Stock
2007-07-02$22.72/sh+7,000$159,032→ 10,552 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2007-07-02$52.79/sh−7,000$369,504→ 0 totalExercise: $22.72From: 2001-08-04Exp: 2010-08-04→ Common Stock (7,000 underlying)
Holdings
- 15,000
Non-Qualified Stock Option (right to buy)
Exercise: $31.66From: 2003-04-29Exp: 2012-04-29→ Common Stock (15,000 underlying) - 14,891
Non-Qualified Stock Option (right to buy)
Exercise: $52.76From: 2007-05-05Exp: 2013-05-05→ Common Stock (14,891 underlying) - 10,000
Non-Qualified Stock Option (right to buy)
Exercise: $26.11From: 2005-05-05Exp: 2014-05-05→ Common Stock (10,000 underlying) - 17,000
Non-Qualified Stock Option (right to buy)
Exercise: $41.15From: 2006-07-27Exp: 2015-07-27→ Common Stock (17,000 underlying) - 11,230
Non-Qualified Stock Option (right to buy)
Exercise: $33.15From: 2002-04-30Exp: 2011-04-30→ Common Stock (11,230 underlying)
Footnotes (1)
- [F1]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.